Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Study of How People Make Decisions About Prostate Cancer Risk

View source ↗

Summary

Memorial Sloan Kettering Cancer Center is recruiting for a study examining how people make decisions about their risk of prostate cancer, including BRCA1/2 gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: BRCA1/2, Geneitic Testing | Status: RECRUITING